Continuum Advisory’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.79K Buy
+565
New +$3.76K ﹤0.01% 1482
2025
Q2
Sell
-403
Closed -$3.21K 1440
2025
Q1
$3.21K Sell
403
-120
-23% -$1.21K ﹤0.01% 1207
2024
Q4
$4.75K Hold
523
﹤0.01% 1149
2024
Q3
$4.69K Buy
523
+88
+20% +$728 ﹤0.01% 1176
2024
Q2
$4.25K Sell
435
-19
-4% -$232 ﹤0.01% 1109
2024
Q1
$5.56K Buy
+454
New +$8.24K ﹤0.01% 1048

Other funds holding TDOC

Continuum Advisory's TDOC Position: Q2 2026 in Review

Continuum Advisory opened a new position in Teladoc Health (TDOC) in Q2 2026: 565 shares worth $4.79K. The stake represents ﹤0.01% of the portfolio and ranks #1482 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in TDOC as recently as Q1 2025.

Continuum Advisory first reported a position in TDOC in Q1 2024 and has held it in 6 quarters since. The position peaked at $5.56K in Q1 2024. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Continuum Advisory held 565 shares of Teladoc Health worth $4.79K as of Q2 2026.
  • Teladoc Health was a new Continuum Advisory position in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1482 holding.
  • Continuum Advisory first reported a position in Teladoc Health in Q1 2024 and has held it in 6 quarters since.
  • Continuum Advisory's Teladoc Health position peaked at $5.56K in Q1 2024.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.